CORE LABORATORIES N V Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Core Laboratories N V quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2019 to Q1 2023.
  • Core Laboratories N V Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2023 was $14.2M, a 30% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $14.2M +$3.28M +30% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $9.15M -$2.33M -20.3% Dec 31, 2022 10-K 2023-02-10
Q3 2022 $10.2M -$2.98M -22.7% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $10.1M -$3.4M -25.2% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $11M -$4.73M -30.2% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $11.5M -$3.42M -23% Dec 31, 2021 10-K 2022-02-10
Q3 2021 $13.1M -$2.22M -14.4% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $13.5M -$3.29M -19.6% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $15.7M -$1.88M -10.7% Mar 31, 2021 10-Q 2021-04-23
Q4 2020 $14.9M -$3.8M -20.3% Dec 31, 2020 10-K 2021-02-08
Q3 2020 $15.4M -$3.64M -19.2% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $16.8M Jun 30, 2020 10-Q 2020-07-24
Q1 2020 $17.6M Mar 31, 2020 10-Q 2020-04-24
Q4 2019 $18.7M Dec 31, 2019 10-K 2020-02-10
Q3 2019 $19M Sep 30, 2019 10-Q 2019-10-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.